Evercore rates Merck as outperform while the company tests anti-viral Covid therapies

Umer Raffat of Evercore ISI joins Closing Bell to discuss Pfizer's and Merck's trials of anti-viral therapies for Covid. The therapies are "not a magic cure," Raffat tells Wilfred Frost, but will help fight the virus.